Vor Biopharma (NYSE:VOR – Get Rating)‘s stock had its “outperform” rating restated by stock analysts at Oppenheimer in a note issued to investors on Friday, Benzinga reports. They presently have a $18.00 target price on the stock. Oppenheimer’s target price would indicate a potential upside of 208.75% from the company’s current price. Several other research […]
Should You Buy or Sell Vor Biopharma Stock? Get The Latest VOR Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Rating) have earned an average recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year […]
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price […]